HOWL (Werewolf Therapeutics) Unearned Income

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HOWL Werewolf Therapeutics Inc HOWL
22 GF Score
Price $0.97
! 3 Warning Signs
View Full Analysis

What is Werewolf Therapeutics Unearned Income?

Unearned Income only applies to banks.

HOWL
22GF Score
Werewolf Therapeutics Inc HOWL
Unearned Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Werewolf Therapeutics Business Description

Address 200 Talcott Avenue, 2nd Floor, Watertown, MA, USA, 02472
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
22GF Score

Get the complete analysis for HOWL

Unearned Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.97
Price